Contraceptive polypeptides

Claim 2

Polypeptides containing at least four, and up to about eight, amino acids, the four amino acids being: 1. selected from the group consisting of threonine, proline, arginine, lysine, serine, hydroxyproline, ornithine and histidine; and 2. formed in a tetrapeptide unit, the amino terminus of which is the amino acid threonine or serine, said threonine or serine being formed in a peptide bond through its carboxyl group to the amino group of proline or hydroxyproline; the remaining two amino acids in said tetrapeptide unit being selected from the group consisting of arginine, lysine, ornithine and histidine, and pharmacologically acceptable salts thereof.

Claim 3

Polypeptides of claim 1 containing four amino acids in which the amino terminus is threonine or serine and pharmacologically acceptable salts thereof.

Claim 4

Polypeptides of claim 2 wherein the amino terminus is threonine or serine and joined in a peptide bond through its carboxyl group to the amino group of proline or hydroxyproline and the remaining two amino acids are selected from the group consisting of arginine and lysine and pharmacologically acceptable salts thereof.

Claim 5

Polypeptides of claim 3 wherein the sequence of the said remaining two acids is arginine joined through its carboxyl group to the alpha amino group of lysine and pharmacologically acceptable salts thereof.

Claim 6

Polypeptides of claim 3 wherein sequence of the said remaining two acids is lysine joined through its carboxyl group to the amino group of arginine and the pharmacologically acceptable salts thereof.

Claim 7

Thr-Pro-Arg-Lys and pharmacologically acceptable salts thereof.

Claim 8

Thr-Pro-Arg-Lys and pharmacologically acceptable salts thereof.

Claim 9

Thr-Pro-Lys-Arg and pharmacologically acceptable salts thereof.

Claim 10

Thr-Pro-Lys-Arg and pharmacologically acceptable salts thereof.

Claim 11

Thr-HyPro-Arg-Lys and pharmacologically acceptable salts thereof.

Claim 12

Thr-HyPro-Arg-Lys and pharmacologically acceptable salts thereof.

Claim 13

Thr-HyPro-Lys-Arg and pharmacologically acceptable salts thereof.

Claim 14

Thr-HyPro-Lys-Arg and pharmacologically acceptable salts thereof.

Claim 15

A composition comprising a pharmaceutically acceptable carrier and at least one compound selected from the group consisting of polypeptides containing at least four, and up to about eight, amino acids, the four amino acids being: 1. selected from the group consisting of threonine, proline, arginine, lysine serine, hydroxyproline, ornithine and histidine; and 2. formed in a tetrapeptide unit, the amino terminus of which is the amino acid threonine or serine, said threonine or serine being formed in a peptide bond through its carboxyl group to the amino group of proline or hydroxyproline; the remaining two amino acids in said tetrapeptide unit being selected from the group consisting of arginine, lysine, ornithine and histidine, and pharmacologically acceptable salts thereof.

Claim 16

A composition comprising a pharmaceutically acceptable carrier and at least one compound selected from the group consisting of polypeptides containing at least four, and up to about eight, amino acids, the four amino acids being: 1. selected from the group consisting of threonine, proline, arginine, lysine serine, hydroxyproline, ornithine and histidine; and 2. formed in a tetrapeptide unit, the amino terminus of which is the amino acid threonine or serine, said threonine or serine being formed in a peptide bond through its carboxyl group to the amino group of proline or hydroxyproline; the remaining two amino acids in said tetrapeptide unit being selected from the group consisting of arginine, lysine, ornithine and histidine, and pharmacologically acceptable salts thereof.

Claim 17

A composition comprising a pharmaceutically acceptable carrier and at least one compound selected from the group consisting of polypeptides of claim 10 containing four amino acids in which the amino terminus is threonine or serine and pharmacologically acceptable salts thereof.

Claim 18

A composition comprising a pharmaceutically acceptable carrier and at least one compound selected from the group consisting of polypeptides of claim 11 wherein the amino terminus is threonine or serine and joined in a peptide bond through its carboxyl group to the amino group of proline or hydroxyproline and the remaining two amino acids are selected from the group consisting of arginine and lysine and pharmacologically acceptable salts thereof.

Claim 19

A composition comprising a pharmaceutically acceptable carrier and at least one compound selected from the group consisting of polypeptides of claim 12 wherein the sequence of the said remaining two acids is arginine joined through its carboxyl group to the alpha amino group of lysine and pharmacologically acceptable salts thereof.

Claim 20

A composition comprising a pharmaceutically acceptable carrier and at least one compound selected from the group consisting of polypeptides of claim 12 wherein sequence of said remaining two acids is lysine joined through its carboxyl group to the amino group of arginine and the phamacologically acceptable salts thereof.

Claim 21

A composition comprising a pharmaceutically acceptable carrier together with a compound selected from the group consisting of Thr-Pro-Arg-Lys and pharmacologically acceptable salts thereof.

Claim 22

A composition comprising a pharmaceutically acceptable carrier together with a compound selected from the group consisting of Thr-Pro-Arg-Lys and pharmacologically acceptable salts thereof.

Claim 23

A composition comprising a pharmaceutically acceptable carrier together with a compound selected from the group consisting of Thr-Pro-Lys-Arg and pharmacologically acceptable salts thereof.

Claim 24

A composition comprising a pharmaceutically acceptable carrier together with a compound selected from the group consisting of Thr-Pro-Lys-Arg and pharmacologically acceptable salts thereof.

Claim 25

A composition comprising a pharmaceutically acceptable carrier together with a compound selected from the group consisting of Thr-HyPro-Arg-Lys and pharmacologically acceptable salts thereof.

Claim 26

A composition comprising a pharmaceutically acceptable carrier together with a compound selected from the group consisting of Thr-HyPro-Arg-Lys and pharmacologically acceptable salts thereof.

Claim 27

A composition comprising a pharmaceutically acceptable carrier together with a compound selected from the group consisting of Thr-HyPro-Lys-Arg and pharmacologically acceptable salts thereof.

Claim 28

A composition comprising a pharmaceutically acceptable carrier together with a compound selected from the group consisting of Thr-HyPro-Lys-Arg and pharmacologically acceptable salts thereof.